Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Pharm Stat ; 18(3): 377-387, 2019 05.
Artigo em Inglês | MEDLINE | ID: mdl-30689280

RESUMO

Applied statisticians and pharmaceutical researchers are frequently involved in the design and analysis of clinical trials where at least one of the outcomes is binary. Treatments are judged by the probability of a positive binary response. A typical example is the noninferiority trial, where it is tested whether a new experimental treatment is practically not inferior to an active comparator with a prespecified margin δ. Except for the special case of δ = 0, no exact conditional test is available although approximate conditional methods (also called second-order methods) can be applied. However, in some situations, the approximation can be poor and the logical argument for approximate conditioning is not compelling. The alternative is to consider an unconditional approach. Standard methods like the pooled z-test are already unconditional although approximate. In this article, we review and illustrate unconditional methods with a heavy emphasis on modern methods that can deliver exact, or near exact, results. For noninferiority trials based on either rate difference or rate ratio, our recommendation is to use the so-called E-procedure, based on either the score or likelihood ratio statistic. This test is effectively exact, computationally efficient, and respects monotonicity constraints in practice. We support our assertions with a numerical study, and we illustrate the concepts developed in theory with a clinical example in pulmonary oncology; R code to conduct all these analyses is available from the authors.


Assuntos
Pesquisa Biomédica/estatística & dados numéricos , Determinação de Ponto Final/estatística & dados numéricos , Estudos de Equivalência como Asunto , Pesquisadores/estatística & dados numéricos , Distribuição Binomial , Pesquisa Biomédica/métodos , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Carcinoma Pulmonar de Células não Pequenas/epidemiologia , Determinação de Ponto Final/métodos , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/epidemiologia , Compostos de Platina/uso terapêutico
2.
Stat Med ; 32(20): 3415-23, 2013 Sep 10.
Artigo em Inglês | MEDLINE | ID: mdl-23553466

RESUMO

For stratified 2 × 2 tables, standard approximate confidence limits can perform poorly from a strict frequentist perspective, even for moderate-sized samples, yet they are routinely used. In this paper, I show how to use importance sampling to compute highly accurate limits in reasonable time. The methodology is very general and simple to implement, and orders of magnitude are faster than existing alternatives.


Assuntos
Ensaios Clínicos como Assunto/métodos , Intervalos de Confiança , Interpretação Estatística de Dados , Fosfatase Ácida/sangue , Fatores Etários , Idoso , Simulação por Computador , Humanos , Linfonodos/patologia , Masculino , Pessoa de Meia-Idade , Neoplasias da Próstata/patologia
3.
Stat Med ; 26(28): 5136-46, 2007 Dec 10.
Artigo em Inglês | MEDLINE | ID: mdl-17437251

RESUMO

We compare various one-sided confidence limits for the odds ratio in a 2 x 2 table. The first group of limits relies on first-order asymptotic approximations and includes limits based on the (signed) likelihood ratio, score and Wald statistics. The second group of limits is based on the conditional tilted hypergeometric distribution, with and without mid-P correction. All these limits have poor unconditional coverage properties and so we apply the general transformation of Buehler (J. Am. Statist. Assoc. 1957; 52:482-493) to obtain limits which are unconditionally exact. The performance of these competing exact limits is assessed across a range of sample sizes and parameter values by looking at their mean size. The results indicate that Buehler limits generated from the conditional likelihood have the best performance, with a slight preference for the mid-P version. This confidence limit has not been proposed before and is recommended for general use, especially when the underlying probabilities are not extreme.


Assuntos
Intervalos de Confiança , Interpretação Estatística de Dados , Funções Verossimilhança , Ensaios Clínicos Controlados Aleatórios como Assunto/estatística & dados numéricos , Animais , Modelos Animais de Doenças , Camundongos , Neoplasias Experimentais/induzido quimicamente , Razão de Chances , Tamanho da Amostra , Fumaça/efeitos adversos , Nicotiana/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA